Accumulate Strides Pharma Science, target price Rs 355: Geojit

Geojit has accumulate call on Strides Pharma Science with a target price of Rs 355. The current market price of Strides Pharma Science Ltd. is Rs 316.15 Time period given by analyst is one year when Strides Pharma Science Ltd. price can reach defined target.

Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2836.92 Crore) operating in Pharmaceuticals sector.

Strides Pharma Science Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Sale of services, Export Incentives and Royalty Income for the year ending 31-Mar-2021.



Financials
For the quarter ended 31-03-2022, the company has reported a Consolidated Total Income of Rs 952.08 Crore, up 18.33 % from last quarter Total Income of Rs 804.58 Crore and up 3.31 % from last year same quarter Total Income of Rs 921.54 Crore. Company has reported net profit after tax of Rs 72.60 Crore in latest quarter.

Investment Rationale
The brokerage expects a revenue CAGR of 20% over FY22-FY24E on the portfolio expansion, healthy order book, better cash flows and focus on debt & cost reduction

Promoter/FII Holdings
Promoters held 30.6 per cent stake in the company as of 31-Mar-2022, while FIIs owned 24.61 per cent, DIIs 13.87 per cent.